← 返回

犬淋巴肿瘤细胞系和正常淋巴细胞中 T 细胞受体β链恒定基因 TRBC1 和 TRBC2 的序列多样性与表达谱

英文原题:Sequence Diversity and Expression Profiles of T Cell Receptor Beta Chain Constant Genes TRBC1 and TRBC2 in Canine Lymphoid Tumour Cell Lines and Normal Lymphocytes.

查看英文原题

Sequence Diversity and Expression Profiles of T Cell Receptor Beta Chain Constant Genes TRBC1 and TRBC2 in Canine Lymphoid Tumour Cell Lines and Normal Lymphocytes.

PubMed 2025/07/19(内容时间) Vet Comp Oncol Q2 · IF 1.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

T细胞受体β链恒定基因TRBC1和TRBC2在成熟人类T细胞中具有微妙的序列多样性和互斥表达模式,这为免疫靶向策略提供了基础,该策略旨在消除克隆性扩增的恶性T细胞,同时保留能够维持免疫 competence 的一部分正常T细胞。哺乳动物中TRBC基因座的进化保守基因排列和调控使这些基因成为伴侣物种(包括犬)转化性免疫靶向策略的有吸引力的靶点。

然而,与常见犬种相关的可用TRBC序列数据仍然有限。在本研究中,我们调查了代表14个不同犬种的外周血单个核细胞(PBMC)样本以及六株已建立的犬造血细胞系(包括T细胞和非T细胞来源,即B和NK细胞系)中犬TRBC1和TRBC2基因的序列多样性和mRNA表达谱。

我们的分析发现了一个先前未报道的TRBC1序列变异,该变异编码跨膜区,但在TRBC1和TRBC2的胞外域中未发现序列多样性。在所有犬种的PBMC批量样本中,一致观察到TRBC1和TRBC2的mRNA表达几乎相等,而犬细胞系则表现出更偏斜的表达谱。出乎意料的是,TRBC的种系mRNA表达存在于一些B细胞来源的犬细胞系(即CLB70、GL1)中,但不存在于其他细胞系(即CLBL1)中。

总之,我们的发现表明,犬TCRβ链变体胞外域中完全保守的氨基酸序列对差异化治疗性抗体的开发提出了挑战。此外,在某些犬B细胞肿瘤中存在胚系TRBC转录本,而在其他肿瘤中则不存在,这可能为这些肿瘤起源的发育阶段提供更多见解。

展开英文摘要原文

The subtle sequence diversity and mutually exclusive expression patterns of T cell receptor beta chain constant genes, TRBC1 and TRBC2, in mature human T cells, provide the basis for immune-targeting strategies designed to eliminate clonally expanded malignant T cells while sparing a subset of normal T cells capable of maintaining immunocompetence. The evolutionarily conserved gene arrangement and regulation of TRBC loci in mammals make these genes attractive targets for translational immune-targeting strategies in companion species, including dogs.

However, available TRBC sequence data relevant to common dog breeds remains limited. In this study, we investigated the sequence diversity and mRNA expression profiles of canine TRBC1 and TRBC2 genes in peripheral blood mononuclear cell (PBMC) samples representing 14 different dog breeds, and in six established canine haematopoietic cell lines of both T-cell and non-T-cell origin (i. e. , B and NK cell lines).

Our analysis uncovered a previously unreported variation in the TRBC1 sequence encoding the transmembrane region but found no sequence diversity in the extracellular domain of TRBC1 and TRBC2. A nearly equal mRNA expression of TRBC1 and TRBC2 was consistently observed in bulk samples of canine PBMCs across all breeds, in contrast to canine cell lines, which exhibited a more skewed expression profile. Unexpectedly, germline mRNA expression of TRBC was present in some (i. e. , CLB70, GL1) but not other (i. e. , CLBL1) canine cell lines of B cell origin.

In conclusion, our findings indicate that the fully conserved amino acid sequence in the extracellular domain of canine TCR beta chain variants presents a challenge for the development of differential therapeutic antibodies.

Additionally, the presence of germline TRBC transcripts in certain canine B-cell neoplasms, but not others, may provide additional insights into the developmental stages from which these neoplasms originate.

论文信息

作者
Pieczka M、Moniakowski L、Studzińska A、Kubiak-Nowak D、Pawlak A、Miazek A
单位
Department of Biochemistry and Molecular Biology, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.Poland
期刊
Veterinary and comparative oncology2025 Dec
原文标识
PubMed 41236719 · DOI 10.1111/vco.70003